Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.49%23.03B | 7.84%20.84B | 3.66%5.07B | 4.59%5.44B | 5.16B | 5.17B | 19.33B | 4.89B | 5.2B |
| Cost of revenue | |||||||||
| Gross profit | |||||||||
| Operating expense | -2.53%20.93B | 8.80%21.47B | -0.29%5.24B | 0.19%5.3B | 5.41B | 5.53B | 19.74B | 5.26B | 5.29B |
| Operating profit | 434.71%2.1B | -54.68%-628M | 53.59%-168M | 272.62%145M | -251M | -355M | -406M | -362M | -84M |
| Net non-operating interest income (expenses) | 118.65%36M | -56.91%-193M | -96.10%-151M | 0.00%-15M | -14M | -14M | -123M | -77M | -15M |
| Non-operating interest income | 12,800.00%129M | --1M | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | -52.06%93M | 57.72%194M | 96.10%151M | 0.00%15M | --14M | --14M | --123M | --77M | --15M |
| Net investment income | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||||
| Income from associates and other participating interests | |||||||||
| Special income (charges) | |||||||||
| Other non-operating income (expenses) | |||||||||
| Income before tax | 360.85%2.14B | -55.60%-820M | 27.40%-318M | 233.67%131M | -264M | -368M | -527M | -438M | -98M |
| Income tax | 2,570.00%801M | 135.71%30M | 160.83%73M | 463.64%80M | -37M | -85M | -84M | -120M | -22M |
| Net income | 257.11%1.34B | -92.10%-851M | -23.97%-393M | 167.11%51M | -227M | -282M | -443M | -317M | -76M |
| Net income continuous operations | 257.41%1.34B | -91.87%-850M | -22.96%-391M | 167.11%51M | ---227M | ---283M | ---443M | ---318M | ---76M |
| Noncontrolling interests | 45.45%-12M | -22M | -4M | -4M | -7M | -6M | 0 | 0 | 0 |
| Net income attributable to the company | 263.04%1.35B | -86.91%-828M | -22.40%-388M | 172.37%55M | -219M | -276M | -443M | -317M | -76M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 263.04%1.35B | -86.91%-828M | -22.40%-388M | 172.37%55M | -219M | -276M | -443M | -317M | -76M |
| Gross dividend payment | |||||||||
| Basic earnings per share | 262.11%13.86 | -86.27%-8.55 | -21.95%-4 | 173.42%0.58 | -2.27 | -2.86 | -4.59 | -3.28 | -0.79 |
| Diluted earnings per share | 260.58%13.73 | -86.27%-8.55 | -21.95%-4 | 172.15%0.57 | -2.27 | -2.86 | -4.59 | -3.28 | -0.79 |
| Dividend per share | |||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |